{
    "Symbol": "UTHR",
    "AssetType": "Common Stock",
    "Name": "United Therapeutics Corporation",
    "Description": "United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.",
    "CIK": "1082554",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1040 SPRING ST, SILVER SPRING, MD, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "14578876000",
    "EBITDA": "1325100000",
    "PERatio": "15.07",
    "PEGRatio": "7.8",
    "BookValue": "128.25",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "21.75",
    "RevenuePerShareTTM": "56.45",
    "ProfitMargin": "0.409",
    "OperatingMarginTTM": "0.448",
    "ReturnOnAssetsTTM": "0.118",
    "ReturnOnEquityTTM": "0.193",
    "RevenueTTM": "2616700000",
    "GrossProfitTTM": "1784700000",
    "DilutedEPSTTM": "21.75",
    "QuarterlyEarningsGrowthYOY": "0.116",
    "QuarterlyRevenueGrowthYOY": "0.198",
    "AnalystTargetPrice": "338.35",
    "AnalystRatingStrongBuy": "6",
    "AnalystRatingBuy": "7",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "15.07",
    "ForwardPE": "13.39",
    "PriceToSalesRatioTTM": "5.57",
    "PriceToBookRatio": "2.558",
    "EVToRevenue": "4.624",
    "EVToEBITDA": "7.97",
    "Beta": "0.555",
    "52WeekHigh": "343.98",
    "52WeekLow": "208.62",
    "50DayMovingAverage": "306.0",
    "200DayMovingAverage": "250.9",
    "SharesOutstanding": "44491200",
    "DividendDate": "None",
    "ExDividendDate": "None"
}